August 15, 2023
VIA EDGAR TRANSMISSION
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jimmy McNamara
Re:
Vaxxinity , Inc.
Registration Statement on Form S-3
Registration No. 333-273822
Dear Mr. McNamara:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of
the effective date of the Registration Statement on Form S-3 (File No. 333-273822) (the “Registration
Statement”) of Vaxxinity , Inc. We respectfully request that the Registration Statement be declared effective as
of 4:00 P.M. Eastern Time on August 18, 2023, or as soon as practicable thereafter, or at such other time as our
legal counsel, Davis Polk & Wardwell LLP, may request by a telephone call to the staff of the U.S. Securities
and Exchange Commission.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel,
Davis Polk & Wardwell LLP, by calling Yasin Keshvargar at (212) 450-4839.
Very truly yours,
Vaxxinity , Inc.
By:
/s/ Mei Mei Hu
Name: Mei Mei Hu
Title: Chief Executive Officer